Childhood gender dysphoria does not become a medical (endocrine) condition unless professionals make it one by using puberty blockers and “high dose cross sex” hormones to prevent normal physical development. This chemical treatment has significant consequences that “include potential sterility, sexual dysfunction, thromboembolic and cardiovascular disease, and malignancy.” It also requires lifelong chemical dependency to maintain the “therapy.” Michael K. Laidlaw, et al., Letter to the Editor: “Endocrine Treatment of Gender- Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline” The Journal of Clinical Endocrinology & Metabolism (2018).